1 year return (CAGR)
364.29%
G1 Therapeutics Inc Exchange (NASDAQ, USD)
GTHX
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-19.82%
5 year return (CAGR)
-28.49%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
377.22M
Price/Sales
6.48
Ent value
436.18M
Price/Book
15.34
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-18.38%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 7.15 |
| Daily high | 7.16 |
| Daily low | 7.14 |
| Daily Volume | 0K |
| 1y analyst estimate | 7.15 |
| Beta | 1.68 |
| EPS (TTM) | -0.85 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GTHX | S&P500 | |
| Current price drop from All-time high | -89.48% | -0.32% |
| Highest price drop | -98.35% | -56.47% |
| Date of highest drop | 12 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -66.84% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 1512 days | 1805 days |
News
No items found